Globally, there are limited data on COVID-19 illness and vaccination during pregnancy to inform recommendations for pregnant people and their care providers and to guide public health policies.

For that reason, the COVID-19 Immunity Task Force (CITF) and CanCOVID are eager to share the latest research from three CITF-supported studies on the impact of SARS-CoV-2 infection and COVID-19 vaccination on pregnancy and newborns.

Among the topics to be addressed:

• The increased risk of serious illness requiring hospital admission for pregnant people with a SARS-CoV-2 infection.
• The higher risk of consequences to the baby (e.g. premature birth, low birth weight).
• Results from a recent study on pregnancy outcomes among individuals who received COVID-19 vaccines during pregnancy, compared with unvaccinated individuals.
• The presence of SARS-CoV-2 antibodies in breastmilk and the value of breastfeeding following infection and vaccination.

The results from these studies are communicated regularly to public health officials to help inform decision-making for ongoing COVID-19 vaccine administration programs in Canada.

Please join us for the presentation which will be followed by a panel discussion and a question-and-answer period.